Clinical Trial Update: Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5% [Phase 4]

View source ↗

Summary

A completed Phase 4 trial characterizes scalp T cells in alopecia areata before and after treatment with Aldara 5% (imiquimod).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Aldara 5% (imiquimod)

Snippet

Sponsor: Hordinsky, Maria K., MD | Conditions: Alopecia Areata | Phase 4 | Status: COMPLETED